Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma
NCT00380354 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2012-06-04
Summary
This study will evaluate the efficacy and safety of GSK256066 in the treatment of subjects with mild bronchial asthma, using a number of clinical and biological markers of efficacy.
Conditions
- Asthma
- Mild Asthma
Interventions
- DRUG
-
GSK256066
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Completion
- 2007-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma
NCT02567708 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.
NCT00603382 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.
NCT00603278 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers
NCT00411814 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
NCT01462617 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age
NCT01156792 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
NCT01370317 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.
NCT00398645 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma
NCT00843193 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Pharmacokinetics of QAW039
NCT01253603 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
NCT01159912 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma
NCT06637254 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic Asthma
NCT03138811 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
NCT01197794 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects
NCT03622112 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma
NCT03207243 ·Status: COMPLETED ·Phase: PHASE2
-
GB001 in Adult Subjects With Moderate to Severe Asthma
NCT03683576 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of SA09012 in Asthma
NCT01740986 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation Of A New Medication (GW642444) In Asthmatic Patients
NCT00354874 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma
NCT00766090 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study in Subjects With Asthma
NCT00980200 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma
NCT02753764 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics
NCT00857857 ·Status: COMPLETED ·Phase: PHASE2
-
A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.
NCT01160003 ·Status: COMPLETED ·Phase: PHASE1